Breaking News Instant updates and real-time market news.

2021-02-22 16:08:37 BCC Boise Cascade $52.32 / +0.58 (+1.12%) 16:08 02/22/21 02/22 16:08 02/22/21 16:08	Boise Cascade reports Q4 EPS with items 66c, consensus $1.08 Reports Q4 revenue $1.47B, consensus $1.34B. Fourth quarter EPS were negatively impacted by $1.10 per share by the following non-cash items that negatively effected reported earnings: $6.2M of pre-tax pension settlement charges, or 12c per share after-tax, related to the elimination of qualified defined benefit pension plan; and $38.8M of income tax expense, or 98c per share, related to the release of stranded tax effects upon Plan Termination. "In the face of many challenges presented by extraordinary market conditions and the pandemic, I am proud that we delivered the best safety performance in our Company's history in 2020. Our associates showed great resilience, and we fully leveraged our proven values to provide direction and clarity to our team during these unprecedented times. We reinvested in our businesses through door shop expansions in Texas, facility expansions in a few key distribution markets, and the log utilization center project at our Florien mill. We also provided dividends to our shareholders and supported our team and communities in response to natural disasters in Louisiana and Oregon. I am optimistic and confident about 2021 and the future of Boise Cascade," commented Nate Jorgensen, CEO.	23 Feb 19 Mar
BCC Boise Cascade $52.32 / +0.58 (+1.12%) 10/30/20 Benchmark Boise Cascade upgraded to Buy from Hold at Benchmark 09/11/20 Fly Intel: Top five analyst downgrades 09/11/20 BofA Boise Cascade downgraded to Neutral from Buy at BofA 09/11/20 BofA Boise Cascade downgraded to Neutral from Buy at BofA

2021-02-22 16:08:37

BCC

Boise Cascade

$52.32 / +0.58 (+1.12%)

16:08

02/22/21

02/22

16:08

02/22/21

16:08

Boise Cascade reports Q4 EPS with items 66c, consensus $1.08

Reports Q4 revenue $1.47B, consensus $1.34B. Fourth quarter EPS were negatively impacted by $1.10 per share by the following non-cash items that negatively effected reported earnings: $6.2M of pre-tax pension settlement charges, or 12c per share after-tax, related to the elimination of qualified defined benefit pension plan; and $38.8M of income tax expense, or 98c per share, related to the release of stranded tax effects upon Plan Termination. "In the face of many challenges presented by extraordinary market conditions and the pandemic, I am proud that we delivered the best safety performance in our Company's history in 2020. Our associates showed great resilience, and we fully leveraged our proven values to provide direction and clarity to our team during these unprecedented times. We reinvested in our businesses through door shop expansions in Texas, facility expansions in a few key distribution markets, and the log utilization center project at our Florien mill. We also provided dividends to our shareholders and supported our team and communities in response to natural disasters in Louisiana and Oregon. I am optimistic and confident about 2021 and the future of Boise Cascade," commented Nate Jorgensen, CEO.

23
Feb
19
Mar

BCC Boise Cascade

$52.32 / +0.58 (+1.12%)

10/30/20 Benchmark: Boise Cascade upgraded to Buy from Hold at Benchmark

09/11/20: Fly Intel: Top five analyst downgrades

09/11/20 BofA: Boise Cascade downgraded to Neutral from Buy at BofA

09/11/20 BofA: Boise Cascade downgraded to Neutral from Buy at BofA

TODAY'S FREE FLY STORIES

Hot Stocks	Second Sight receives FDA approval for Argus 2s Retinal Prosthesis System » 08:09 03/05/21 03/05 08:09 03/05/21 08:09 EYES Second Sight $1.43 / -0.29 (-16.86%) Second Sight announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate EYES Second Sight $1.43 / -0.29 (-16.86%) 09/22/20 Second Sight resumes early feasibility study of Orion at UCLA EYES Second Sight $1.43 / -0.29 (-16.86%) 04/01/20 H.C. Wainwright Second Sight rating placed under review at H.C. Wainwright 01 May
Hot Stocks	Brickell Biotech to host KOL webinar on the hyperhidrosis market » 08:08 03/05/21 03/05 08:08 03/05/21 08:08 BBI Brickell Biotech $1.17 / + (+0.00%) Brickell Biotech… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Events BBI Brickell Biotech $1.17 / + (+0.00%) 01/19/21 Brickell announces Japan Phase 3 study results for sofpironium bromide gel 12/07/20 Brickell Biotech doses first patient in second U.S. Phase 3 study 11/18/20 Brickell Biotech announces Japan launch date for sofpironium bromide gel, 5% 10/06/20 Brickell Biotech initiates U.S. Phase 3 program of sofpironium bromide gel, 15% BBI Brickell Biotech $1.17 / + (+0.00%) 09/25/20 Lake Street Approval in Japan validating for Brickell Biotech, says Lake Street 08/28/20 Lake Street Brickell Biotech initiated with a Buy at Lake Street 08/25/20 Oppenheimer Brickell Biotech initiated with an Outperform at Oppenheimer 23 Oct 18 Jun 03/10/21 Global Life Sciences Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 03/09/21 Brickell Biotech - BBI
Hot Stocks	Fathom acquires real estate brokerage business of Red Barn Real Estate » 08:08 03/05/21 03/05 08:08 03/05/21 08:08 FTHM Fathom $34.78 / -5.22 (-13.05%) Fathom Holdings announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate FTHM Fathom $34.78 / -5.22 (-13.05%) 02/16/21 Fathom, Zavvie partner for residential real estate service 02/10/21 Fathom signs agreement to acquire technology platform Naberly Solutions 11/05/20 Fathom to acquire Verus Title, terms not disclosed FTHM Fathom $34.78 / -5.22 (-13.05%) 02/10/21 Roth Capital Roth raises Fathom target to $52, sees 'multifold benefits' from Naberly deal 02/09/21 DA Davidson Fathom initiated with a Buy at DA Davidson 01/25/21 Roth Capital Fathom price target raised to $50 from $40 at Roth Capital 12/28/20 Roth Capital Fathom price target raised to $40 from $28 at Roth Capital 28 Jul
Hot Stocks	Immutep expands Part B of TACTI-002 Phase II study » 08:07 03/05/21 03/05 08:07 03/05/21 08:07 IMMP Immutep $2.41 / -0.2 (-7.66%) Immutep is pleased to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly IMMP Immutep $2.41 / -0.2 (-7.66%) 01/27/21 Immutep announces DSMB recommends Phase II trial advance with enrollment 01/21/21 Immutep announces GlaxoSmithKline discontinuation of GSK2831781 trial 01/06/21 Immutep completes recruitment in TACTI-002 phase 3 study trial 12/29/20 Immutep secures U.S. patent for Eftilagimod Alpha IMMP Immutep $2.41 / -0.2 (-7.66%) 01/26/21 Alliance Global Partners Immutep price target raised to $6 from $5 at Alliance Global Partners 12/14/20 Maxim Maxim doubled Immutep price target after breast cancer update 11/11/20 Maxim Immutep price target raised to $4 from $2 at Maxim 09/22/20 Top five analyst initiations IMMP Immutep $2.41 / -0.2 (-7.66%) 12/30/20 Fly Intel: Pre-market Movers 12/29/20 Fly Intel: After-Hours Movers
Recommendations	Joint Corp. price target raised to $54 from $28 at Maxim » 08:07 03/05/21 03/05 08:07 03/05/21 08:07 JYNT Joint Corp. $44.28 / -4.77 (-9.72%) Maxim analyst Anthony… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events JYNT Joint Corp. $44.28 / -4.77 (-9.72%) 01/05/21 Joint Corp. acquires two regional developer territories for $2.4M JYNT Joint Corp. $44.28 / -4.77 (-9.72%) 02/25/21 B. Riley Securities Joint Corp. price target raised to $47 from $26 at B. Riley Securities 01/06/21 Craig-Hallum Joint Corp. price target raised to $38 from $26 at Craig-Hallum 01/04/21 Lake Street Joint Corp. price target raised to $35 from $25 at Lake Street 11/06/20 B. Riley Securities Joint Corp. price target raised to $26 from $22 at B. Riley Securities JYNT Joint Corp. $44.28 / -4.77 (-9.72%) 03/04/21 Joint Corp. sees FY21 revenue $73M-$77M , consensus $72.23M 03/04/21 Joint Corp. reports Q4 EPS 72c, consensus 14c 11/05/20 Joint Corp. reports Q3 EPS 11c, consensus 2c 03/15/21 33rd Annual Roth Virtual Conference

Hot Stocks	Allied Esports confirms proposal from Bally's to acquire the company for $100M » 08:07 03/05/21 03/05 08:07 03/05/21 08:07 AESE Allied Esports Entertainment $3.27 / +0.77 (+30.80%) , BALY Bally's $52.30 / -8.27 (-13.65%) Allied Esports… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events AESE BALY AESE Allied Esports Entertainment $3.27 / +0.77 (+30.80%) 08:00 Today Allied Esports Entertainment Inc trading halted, news dissemination 01/19/21 Allied Esports Entertainment sells World Poker Tour to Element Partners 01/13/21 Allied Esports, HyperX renew naming rights agreement for HyperX Esports Arena 12/17/20 Allied Esports Entertainment, Trovo announce battle royale Esports tournament BALY Bally's $52.30 / -8.27 (-13.65%) 03/04/21 Bally's becomes authorized sports betting operator of the NBA 03/04/21 Bally's CEO seeing 'markedly stronger consumer demand' in January, February 02/22/21 Bally's submits proposal to develop casino in Richmond, Virginia 02/18/21 Bally's becomes official sports betting partner of The National Hockey League AESE BALY AESE Allied Esports Entertainment $3.27 / +0.77 (+30.80%) 06/08/20 Alliance Global Partners Alliance Global says Allied Esports refinancing eliminates near-term overhang 05/15/20 Stephens Allied Esports Entertainment price target lowered to $4 from $5 at Stephens 05/06/20 Alliance Global Partners Allied Esports Entertainment initiated with a Buy at Alliance Global Partners BALY Bally's $52.30 / -8.27 (-13.65%) 06:55 Today Stifel Stifel upgrades Bally's to Buy after 'overplayed' post-earnings dip 05:30 Today Stifel Bally's upgraded to Buy from Hold at Stifel 02/24/21 Truist Bally's price target raised to $80 from $65 at Truist 02/09/21 Stifel Bally's price target raised to $60 from $50 at Stifel BALY BALY Bally's $52.30 / -8.27 (-13.65%) 03/04/21 Bally's reports Q4 adjusted EPS 39c, consensus (8c) 11/09/20 Bally's Corporation changes name from Twin River Worldwide Holdings BALY BALY Bally's $52.30 / -8.27 (-13.65%) 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says AESE BALY AESE Allied Esports Entertainment $3.27 / +0.77 (+30.80%) 02/01/21 Fly Insider:Allied Esports,Applied Optoelectronics among notable insider trades BALY Bally's $52.30 / -8.27 (-13.65%) 02/26/21 Bet On It: Florida and Texas trying to get in on the action 02/19/21 Bet On It: Penn National's lack of promotional spend sets it apart 02/12/21 Bet On It: Texas and Hawaii face opposition to legalized sports betting 02/05/21 Bet On It: Georgia online sports betting bill passes first test 03/15/21 33rd Annual Roth Virtual Conference
Recommendations	Outfront Media price target raised to $24 from $22 at Barrington » 08:07 03/05/21 03/05 08:07 03/05/21 08:07 OUT Outfront Media $21.47 / -0.305 (-1.40%) Barrington analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate On The Fly OUT Outfront Media $21.47 / -0.305 (-1.40%) 03/02/21 Citi Outfront Media price target raised to $25 from $21 at Citi 11/12/20 Citi Outfront Media price target raised to $21 from $18 at Citi 11/02/20 Morgan Stanley Lamar Advertising upgraded at Morgan Stanley with recovery not priced in 09/25/20 Citi Outfront Media upgraded to Buy from Neutral at Citi OUT Outfront Media $21.47 / -0.305 (-1.40%) 02/25/21 Outfront Media reports Q4 EPS (2c), consensus (3c) 11/04/20 Outfront Media reports Q3 adjusted EPS (14c), consensus (18c) 23 Feb OUT Outfront Media $21.47 / -0.305 (-1.40%) 09/25/20 Fly Intel: Pre-market Movers
Hot Stocks	Keros presents results from preclinical studies of KER-050, ALK2 Inhibitors » 08:06 03/05/21 03/05 08:06 03/05/21 08:06 KROS Keros Therapeutics $55.16 / -2.32 (-4.04%) Keros Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly KROS Keros Therapeutics $55.16 / -2.32 (-4.04%) 12/21/20 Keros Therapeutics added to the Nasdaq Biotechnology Index 12/17/20 Keros Therapeutics appoints Mary Ann Gray to board of directors 12/07/20 Keros Therapeutics presents results from ALK2 Inhibitor program 10/20/20 Keros Therapeutics doses first participants in Phase 2 trial of KER-050 KROS Keros Therapeutics $55.16 / -2.32 (-4.04%) 12/08/20 SVB Leerink Keros Therapeutics price target raised to $80 from $42 at SVB Leerink 12/08/20 H.C. Wainwright Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright 12/08/20 Piper Sandler Keros Therapeutics price target raised to $95 from $75 at Piper Sandler 11/18/20 Piper Sandler Keros Therapeutics price target raised to $75 from $55 at Piper Sandler 13 Nov 08 Apr KROS Keros Therapeutics $55.16 / -2.32 (-4.04%) 11/13/20 Fly Intel: Pre-market Movers
Recommendations	Cooper Companies price target raised to $415 from $375 at Raymond James » 08:06 03/05/21 03/05 08:06 03/05/21 08:06 COO Cooper Companies $371.84 / -9.125 (-2.40%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events COO Cooper Companies $371.84 / -9.125 (-2.40%) 02/03/21 Cooper Companies, EssilorLuxottica enter JV to acquire SightGlass Vision 10/09/20 CooperVision presents six-year data from MiSight 1 day study COO Cooper Companies $371.84 / -9.125 (-2.40%) 06:52 Today Baird Cooper Companies price target raised to $384 from $351 at Baird 06:19 Today Citi Cooper Companies price target raised to $378 from $355 at Citi 02/11/21 Piper Sandler Cooper Companies price target raised to $435 from $370 at Piper Sandler 01/25/21 Wells Fargo Cooper Companies price target raised to $445 from $415 at Wells Fargo COO Cooper Companies $371.84 / -9.125 (-2.40%) 03/04/21 Cooper Companies sees FY21 EPS $12.90-$13.10, consensus $12.54 03/04/21 Cooper Companies reports Q1 EPS $3.17, consensus $2.78 12/03/20 Cooper Companies sees Q1 EPS $2.66-$2.86, consensus $2.88 12/03/20 Cooper Companies reports Q4 EPS $3.16, consensus $3.09 COO Cooper Companies $371.84 / -9.125 (-2.40%) 03/04/21 Fly Intel: After-Hours Movers 03/17/21 The Cooper Companies Inc.
Hot Stocks	PriceSmart announces February net merchandise sales up 1.3% to $258.7M » 08:06 03/05/21 03/05 08:06 03/05/21 08:06 PSMT PriceSmart $91.39 / -3.43 (-3.62%) PriceSmart announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly PSMT PriceSmart $91.39 / -3.43 (-3.62%) 02/05/21 PriceSmart announces January net merchandise sales up 5.2% to $267.1M 02/03/21 PriceSmart to open ninth warehouse club in Colombia 01/08/21 PriceSmart reports fiscal YTD net merchandise sales up 6.1% to $1.211B 01/08/21 PriceSmart announces December net merchandise sales up 2.8% to $372.6M PSMT PriceSmart $91.39 / -3.43 (-3.62%) 05/08/20 Scotiabank Scotiabank downgrades PriceSmart amid COVID-19 restrictions 05/08/20 Scotiabank PriceSmart downgraded to Sector Perform from Outperform at Scotiabank PSMT PriceSmart $91.39 / -3.43 (-3.62%) 01/07/21 PriceSmart reports Q1 EPS 90c, two estimates 68c 10/29/20 PriceSmart reports Q4 EPS 65c vs. 67c last year PSMT PriceSmart $91.39 / -3.43 (-3.62%) 01/07/21 Fly Intel: After-Hours Movers

Recommendations	NGM Biopharmaceuticals price target raised to $44 from $39 at Chardan » 08:06 03/05/21 03/05 08:06 03/05/21 08:06 NGM NGM Biopharmaceuticals $27.10 / -1.36 (-4.78%) Chardan analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly NGM NGM Biopharmaceuticals $27.10 / -1.36 (-4.78%) 03/02/21 NGM Biopharmaceuticals initiates expansion of Phase 1b study of NGM120 12/09/20 NGM Biopharmaceuticals announces NGM438 featured during R&D Day 11/13/20 NGM Biopharmaceuticals presents Phase 1 safety, PK data for NGM621 10/19/20 NGM announces immuno-oncology development candidate NGM707 NGM NGM Biopharmaceuticals $27.10 / -1.36 (-4.78%) 02/09/21 Goldman Sachs NGM Biopharmaceuticals price target raised to $38 from $28 at Goldman Sachs 01/08/21 Raymond James NGM Biopharmaceuticals price target raised to $50 from $32 at Raymond James 01/05/21 Stifel NGM Biopharmaceuticals named a top pick, price target boosted to $43 at Stifel 12/21/20 Citi NGM Biopharmaceuticals price target raised to $44 from $28 at Citi NGM NGM Biopharmaceuticals $27.10 / -1.36 (-4.78%) 03/04/21 NGM Biopharmaceuticals reports Q4 EPS (40c), consensus (47c) 11/12/20 NGM Biopharmaceuticals reports Q3 EPS (43c), consensus (38c) 06 Jan NGM NGM Biopharmaceuticals $27.10 / -1.36 (-4.78%) 01/04/21 Fly Intel: After-Hours Movers
Recommendations	Purple Innovation price target lowered to $32 from $36 at Raymond James » 08:05 03/05/21 03/05 08:05 03/05/21 08:05 PRPL Purple Innovation $24.42 / -11.76 (-32.50%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options PRPL Purple Innovation $24.42 / -11.76 (-32.50%) 03/04/21 Purple Innovation: Guidance 'true,' QTD not tracking better than guidance 10/19/20 Purple Innovation signs exclusive partnership with Sleep Country Canada PRPL Purple Innovation $24.42 / -11.76 (-32.50%) 06:21 Today UBS Purple Innovation price target lowered to $32 from $44 at UBS 01/12/21 B. Riley Securities Purple Innovation price target raised to $41 from $20 at B. Riley Securities 01/12/21 Wedbush Purple Innovation price target raised to $38 from $32 at Wedbush 12/16/20 Truist Purple Innovation initiated with a Buy at Truist PRPL Purple Innovation $24.42 / -11.76 (-32.50%) 03/04/21 Purple Innovation sees Q1 revenue $160M-$170M, consensus $176.46M 03/04/21 Purple Innovation sees FY21 revenue $840M-$880M, consensus 03/04/21 Purple Innovation reports Q4 adjusted EPS 7c, consensus 11c 11/11/20 Notable companies reporting after market close 10 Sep 15 May PRPL Purple Innovation $24.42 / -11.76 (-32.50%) 11/10/20 Fly Intel: After-Hours Movers 09/10/20 Fly Intel: Pre-market Movers 09/09/20 Fly Intel: After-Hours Movers PRPL Purple Innovation $24.42 / -11.76 (-32.50%) 12/24/20 Purple Innovation call volume above normal and directionally bullish 12/07/20 Unusual call flow in option market yesterday 12/04/20 Unusual call volume in Purple Innovation as shares traded up 4% 12/01/20 Largest borrow rate increases among liquid names
Hot Stocks	Sonim partners with FIH Mobile for next generation feature phones » 08:04 03/05/21 03/05 08:04 03/05/21 08:04 SONM Sonim $0.90 / -0.1102 (-10.91%) , HNHPF Hon Hai Precision $0.00 / + (+0.00%) , QCOM Qualcomm $127.67 / -3.93 (-2.99%) Sonim Technologies (SONM)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SONM HNHPF QCOM SONM Sonim $0.90 / -0.1102 (-10.91%) 03/03/21 Sonim, Energy Electronics sign new Distribution agreement in North America 01/25/21 Sonim announces partnership with Syndico 01/20/21 Sonim receives Nasdaq compliance extension 12/22/20 Sonim announces software development, asset purchase agreement with Coforge HNHPF Hon Hai Precision $0.00 / + (+0.00%) 02/16/21 Amazon to build device manufacturing line in India 01/06/21 Foxconn reports December revenue up 32.3% y/y to NT$13.78B QCOM Qualcomm $127.67 / -3.93 (-2.99%) 03/03/21 Lantronix announces Mobile HDK featuring Qualcomm Snapdragon 888 02/16/21 Appaloosa buys Macy's and Kohl's, exits AT&T in Q4 02/09/21 Globalstar announces inclusion of Band n53 in Qualcomm's X65 modem 02/03/21 Qualcomm down 7% to $151.01 after Q1 earnings, Q2 outlook SONM HNHPF QCOM SONM Sonim $0.90 / -0.1102 (-10.91%) 12/16/20 B. Riley Securities Sonim transferred with Buy rating at B. Riley Securities 03/16/20 Lake Street Sonim price target lowered to $2 from $3 at Lake Street HNHPF Hon Hai Precision $0.00 / + (+0.00%) QCOM Qualcomm $127.67 / -3.93 (-2.99%) 03/04/21 Fly Intel: Top five analyst upgrades 03/04/21 JPMorgan Qualcomm price target lowered to $170 from $185 at JPMorgan 03/04/21 Piper Sandler Qualcomm upgraded to Overweight from Neutral at Piper Sandler 02/10/21 JPMorgan China mobile shipments data point to 'robust' Apple demand, says JPMorgan SONM QCOM SONM Sonim $0.90 / -0.1102 (-10.91%) 02/23/21 Sonim regains compliance with Nasdaq listing requirements 11/11/20 Sonim reports Q3 EPS (10c), consensus (19c) QCOM Qualcomm $127.67 / -3.93 (-2.99%) 02/03/21 Qualcomm sees Q2 EPS $1.55-$1.75, consensus $1.57 02/03/21 Qualcomm reports Q1 EPS $2.17, consensus $2.10 02/03/21 Notable companies reporting after market close 11/04/20 Qualcomm sees Q1 adjusted EPS $1.95-$2.15, consensus $1.68 05 Jun HNHPF QCOM HNHPF Hon Hai Precision $0.00 / + (+0.00%) 02/26/21 Foxconn to manufacture Fire TV Stick devices for Amazon in India, Nikkei says 02/11/21 Startup developing new devices to be sold under BlackBerry brand, Nikkei says 02/08/21 Foxconn-backed Byton could go public via SPAC deal, Reuters reports 01/14/21 Foxconn unit signs JV agreement with Geely Holding, DigiTimes reports QCOM Qualcomm $127.67 / -3.93 (-2.99%) 02/24/21 Biden to address chip shortages with executive action, WSJ reports 02/12/21 Tech companies seek intervention in Nvidia acquisition of Arm, Bloomberg says 02/12/21 FTC opened in-depth investigation of Nvidia's ARM deal, Bloomberg reports 02/12/21 Qualcomm expresses concern over Nvidia's $40B Arm takeover, CNBC reports HNHPF QCOM HNHPF Hon Hai Precision $0.00 / + (+0.00%) 12/05/20 Week in review: How Trump's policies moved stocks QCOM Qualcomm $127.67 / -3.93 (-2.99%) 03/04/21 Snowflake, Qualcomm upgrades among today's top calls on Wall Street 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/24/21 Fly Intel: What to watch in Nvidia earnings report 02/12/21 Fly Intel: Wall Street's top stories for Friday 03/15/21 33rd Annual Roth Virtual Conference 04/28/21 Qualcomm - QCOM 03/10/21 Qualcomm Inc. QCOM QCOM Qualcomm $127.67 / -3.93 (-2.99%) 12/07/20 Qualcomm call buyer realizes 32% same-day gains 12/04/20 Qualcomm call volume above normal and directionally bullish 11/11/20 Qualcomm call volume above normal and directionally bullish 11/11/20 Early notable gainers among liquid option names on November 11th
Hot Stocks	QLHC discontinues testing of Aerpio's razuprotafib in I-SPY COVID trial » 08:04 03/05/21 03/05 08:04 03/05/21 08:04 ARPO Aerpio Pharmaceuticals $1.55 / -0.155 (-9.12%) Quantum Leap Healthcare… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly ARPO Aerpio Pharmaceuticals $1.55 / -0.155 (-9.12%) 01/05/21 Aerpio Pharmaceuticals Inc trading resumes 01/05/21 Aerpio Pharmaceuticals to resume trading at 4:30 p.m. ET 01/05/21 Aerpio Pharmaceuticals to explore, review strategic alternatives 01/05/21 Aerpio Pharmaceuticals Inc trading halted, news pending ARPO Aerpio Pharmaceuticals $1.55 / -0.155 (-9.12%) 12/14/20 H.C. Wainwright Aerpio Pharmaceuticals price target lowered to $1.50 from $2 at H.C. Wainwright 12/09/20 Fly Intel: Top five analyst initiations 12/09/20 BTIG Aerpio Pharmaceuticals initiated with a Buy at BTIG 06/25/20 H.C. Wainwright Aerpio Pharmaceuticals price target raised to $1.50 from $1 at H.C. Wainwright ARPO Aerpio Pharmaceuticals $1.55 / -0.155 (-9.12%) 01/05/21 Fly Intel: After-Hours Movers
Downgrade	Dexus downgraded to Hold from Buy at Jefferies » 08:03 03/05/21 03/05 08:03 03/05/21 08:03 DXSPF Dexus $0.00 / + (+0.00%) Jefferies analyst Sholto… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research DXSPF Dexus $0.00 / + (+0.00%) 10/30/20 JPMorgan Dexus downgraded to Neutral from Overweight at JPMorgan

Earnings	Global Partners reports Q4 EPS 6c, consensus (17c) » 08:03 03/05/21 03/05 08:03 03/05/21 08:03 GLP Global Partners $20.24 / -0.18 (-0.88%) Reports Q4 revenue $2.2B,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events GLP Global Partners $20.24 / -0.18 (-0.88%) 01/26/21 Global Partners boosts quarterly cash distribution to 55c per unit 12/14/20 Global Partners buys retail fuel, convenience stores from Consumers Petroleum 10/26/20 Global Partners boosts quarterly dividend to 50c per share GLP Global Partners $20.24 / -0.18 (-0.88%) 03/24/20 Barclays Global Partners upgraded to Equal Weight from Underweight at Barclays GLP Global Partners $20.24 / -0.18 (-0.88%) 11/05/20 Global Partners reports Q3 EPS 47c, consensus 11c 10:00 Today Global Partners - GLP
Downgrade	Senseonics downgraded to Underperform from Market Perform at Raymond James » 08:02 03/05/21 03/05 08:02 03/05/21 08:02 SENS Senseonics $2.69 / -0.48 (-15.14%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options SENS Senseonics $2.69 / -0.48 (-15.14%) 02/01/21 Ascensia commences sales, marketing activities for Eversense XL CGM 01/21/21 Senseonics Holder Masters reports 5.89% active stake 01/19/21 Senseonics announces positive coverage decision for Eversense CGM 10/05/20 Senseonics submits PMA application for 180-Day Eversense System to the FDA SENS Senseonics $2.69 / -0.48 (-15.14%) 04:51 Today Raymond James Senseonics downgraded to Underperform from Market Perform at Raymond James 01/20/21 BTIG BTIG cuts Senseonics to Neutral, sees no fundamental reason for rapid rise 01/20/21 BTIG Senseonics downgraded to Neutral from Buy at BTIG 01/20/21 Craig-Hallum Senseonics downgraded to Sell at Craig-Hallum SENS Senseonics $2.69 / -0.48 (-15.14%) 03/04/21 Senseonics sees FY21 revenue $12M-$15M, consensus $13.15M 03/04/21 Senseonics reports Q4 EPS (41c), consensus (9c) 12/23/20 Senseonics sees FY21 revenue $12M-$15M, consensus $12.7M 12/23/20 Senseonics sees Q4 revenue $3.5M, consensus $2.49M 22 Jan SENS Senseonics $2.69 / -0.48 (-15.14%) 01/22/21 Fly Intel: Pre-market Movers 12/24/20 Fly Intel: Pre-market Movers SENS Senseonics $2.69 / -0.48 (-15.14%) 03/04/21 Senseonics options imply 28.4% move in share price post-earnings 02/08/21 Unusually active option classes on open February 8th 01/06/21 Largest borrow rate increases among liquid names 12/24/20 Unusually active option classes on open December 24th
Hot Stocks	Oxford Lane estimates February NAV $5.94-$6.04 » 08:02 03/05/21 03/05 08:02 03/05/21 08:02 OXLC Oxford Lane $6.52 / -0.06 (-0.91%) Management's… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings OXLC Oxford Lane $6.52 / -0.06 (-0.91%) 02/04/21 Oxford Lane estimates January NAV $5.84-$5.94 12/03/20 Oxford Lane sees NAV $4.86-$4.96 as of November 30 11/05/20 Oxford Lane sees NAV $3.87-$3.97 as of October 31 09/08/20 Oxford Lane sees NAV $3.71-$3.81 as of August 31 OXLC Oxford Lane $6.52 / -0.06 (-0.91%) 02/01/21 Oxford Lane reports core NII 37c 11/02/20 Oxford Lane reports Q2 core NII 24c
Hot Stocks	Molecular Data, Yili Group reach cooperation agreement » 08:01 03/05/21 03/05 08:01 03/05/21 08:01 MKD Molecular Data $1.06 / -0.14 (-11.67%) Molecular Data announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News MKD Molecular Data $1.06 / -0.14 (-11.67%) 12/02/20 Molecular Data announces resignation of Zhaohong Li as CFO for personal reasons 10/23/20 Molecular Data appoints MarcumBP as public accounting firm
Recommendations	Costco price target lowered to $399 from $435 at RBC Capital » 08:00 03/05/21 03/05 08:00 03/05/21 08:00 COST Costco $319.35 / -4.53 (-1.40%) RBC Capital analyst Scot… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options COST Costco $319.35 / -4.53 (-1.40%) 02/03/21 Costco reports January SSS rose 15.9% 01/06/21 Costco December SSS, ex impact from gas, FX rose 10.9% 01/06/21 Costco December E-commerce sales ex gas, FX up 61.6% 11/24/20 Tinley Beverage Company completes full production at Long Beach facility COST Costco $319.35 / -4.53 (-1.40%) 07:36 Today Stifel Costco price target lowered to $370 from $395 at Stifel 07:01 Today Wells Fargo Costco price target lowered to $340 from $360 at Wells Fargo 06:54 Today Oppenheimer Costco price target lowered to $350 from $400 at Oppenheimer 06:26 Today Citi Costco risk/reward 'starting to skew more positive,' says Citi COST Costco $319.35 / -4.53 (-1.40%) 03/04/21 Costco reports Q2 EPS $2,14, consensus $2.44 03/04/21 Notable companies reporting after market close 12/10/20 Costco reports Q1 total company comparable sales up 15.4% 12/10/20 Costco reports Q1 EPS $2.62, consensus $2.05 COST Costco $319.35 / -4.53 (-1.40%) 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports 12/15/20 FedEx, UPS limiting packages they pick up, creating backlogs, WSJ reports COST Costco $319.35 / -4.53 (-1.40%) 03/04/21 Fly Intel: After-Hours Movers 03/01/21 Fly Intel: What to watch in Target's earnings report 02/26/21 Fly Intel: Wall Street's top stories at midday 12/10/20 Fly Intel: After-Hours Movers 05/27/21 Costco - COST COST Costco $319.35 / -4.53 (-1.40%) 12/10/20 Costco options imply 3.8% move in share price post-earnings 11/17/20 Early notable gainers among liquid option names on November 17th 09/24/20 Costco options imply 6.0% move in share price post-earnings 09/24/20 Unusually active option classes on open September 24th

Hot Stocks	Allied Esports Entertainment Inc trading halted, news dissemination 08:00 03/05/21 03/05 08:00 03/05/21 08:00 AESE Allied Esports Entertainment $3.27 / +0.77 (+30.80%) ShowHide Related Items >><< Company News Street Research On The Fly Events AESE Allied Esports Entertainment $3.27 / +0.77 (+30.80%) 01/19/21 Allied Esports Entertainment sells World Poker Tour to Element Partners 01/13/21 Allied Esports, HyperX renew naming rights agreement for HyperX Esports Arena 12/17/20 Allied Esports Entertainment, Trovo announce battle royale Esports tournament 12/16/20 Allied Esports launches 24-hour cross-channel content strategy on Twitch AESE Allied Esports Entertainment $3.27 / +0.77 (+30.80%) 06/08/20 Alliance Global Partners Alliance Global says Allied Esports refinancing eliminates near-term overhang 05/15/20 Stephens Allied Esports Entertainment price target lowered to $4 from $5 at Stephens 05/06/20 Alliance Global Partners Allied Esports Entertainment initiated with a Buy at Alliance Global Partners AESE Allied Esports Entertainment $3.27 / +0.77 (+30.80%) 02/01/21 Fly Insider:Allied Esports,Applied Optoelectronics among notable insider trades 03/15/21 33rd Annual Roth Virtual Conference
Upgrade	Kinaxis upgraded to Buy from Hold at Stifel » 08:00 03/05/21 03/05 08:00 03/05/21 08:00 KXSCF Kinaxis $0.00 / + (+0.00%) Stifel GMP analyst Deepak… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KXSCF Kinaxis $0.00 / + (+0.00%) 11/06/20 RBC Capital Kinaxis price target raised to C$260 from C$240 at RBC Capital 11/06/20 Scotiabank Kinaxis price target lowered to C$241 from C$252 at Scotiabank 10/16/20 CIBC Kinaxis price target raised to C$288 from C$230 at CIBC 08/07/20 RBC Capital Kinaxis price target raised to C$240 from C$220 at RBC Capital
Options	Marathon Oil call buyer realizes 12% same-day gains » 08:00 03/05/21 03/05 08:00 03/05/21 08:00 MRO Marathon Oil $12.36 / +0.735 (+6.32%) Notable profits for the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MRO Marathon Oil $12.36 / +0.735 (+6.32%) 02/22/21 Marathon Oil reports Q4 oil production 172 net bopd 02/22/21 Marathon Oil to hold Q4 company oil production flat through 2025 02/22/21 Marathon Oil sees FY21 CapEx budget at $1B 01/08/21 Marathon Oil names Warnica Senior Vice President and General Counsel MRO Marathon Oil $12.36 / +0.735 (+6.32%) 01/14/21 Barclays Marathon Oil upgraded to Overweight with $9 target at Barclays 01/14/21 Barclays Marathon Oil upgraded to Overweight from Equal Weight at Barclays 01/14/21 Truist Marathon Oil upgraded to Buy at Truist on 'significant' free cash flow outlook 01/14/21 Truist Marathon Oil upgraded to Buy from Hold at Truist MRO Marathon Oil $12.36 / +0.735 (+6.32%) 02/22/21 Marathon Oil reports Q4 adjusted EPS (12c), consensus (20c) 11/04/20 Marathon Oil sees 2020 total net oil production 188-192 mbbld 11/04/20 Marathon Oil reports Q3 adjusted EPS (28c), consensus (28c) MRO Marathon Oil $12.36 / +0.735 (+6.32%) 02/11/21 Marathon reduces staff and executive pay amid cost-cutting moves, Reuters says MRO Marathon Oil $12.36 / +0.735 (+6.32%) 02/22/21 Fly Intel: After-Hours Movers 10/01/20 Fly Intel: After-Hours Movers MRO Marathon Oil $12.36 / +0.735 (+6.32%) 03/04/21 Marathon Oil call volume above normal and directionally bullish 03/02/21 Early notable gainers among liquid option names on March 2nd 02/22/21 Marathon Oil call volume above normal and directionally bullish 02/22/21 Early notable gainers among liquid option names on February 22nd
Upgrade	SBA Communications upgraded to Strong Buy from Outperform at Raymond James » 07:59 03/05/21 03/05 07:59 03/05/21 07:59 SBAC SBA Communications $235.92 / -3.33 (-1.39%) Raymond James analyst Ric… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals SBAC SBA Communications $235.92 / -3.33 (-1.39%) 02/22/21 Dish signs master lease agreement with SBA Communications 02/02/21 PG&E unit sells rights to 700 towers to SBA Communications for $973M 01/24/21 Fly Intel: Top five weekend stock stories SBAC SBA Communications $235.92 / -3.33 (-1.39%) 05:39 Today Raymond James SBA Communications upgraded to Strong Buy from Outperform at Raymond James 02/23/21 Credit Suisse SBA Communications price target lowered to $277 from $291 at Credit Suisse 02/23/21 Barclays SBA Communications price target raised to $310 from $305 at Barclays 02/23/21 Deutsche Bank SBA Communications price target lowered to $325 from $335 at Deutsche Bank SBAC SBA Communications $235.92 / -3.33 (-1.39%) 02/22/21 SBA Communications sees FY21 AFFO $10-$10.41, consensus $10.12 02/22/21 SBA Communications reports Q4 AFFO $2.49, consensus $2.44 11/02/20 SBA Communications raises FY20 AFFO view to $9.27-$9.50 from $8.94-$9.33 11/02/20 SBA Communications reports Q3 AFFO $2.38, consensus $2.32 SBAC SBA Communications $235.92 / -3.33 (-1.39%) 01/23/21 SBA, Equinix among names to buy in year of digital infrastructure, Barron's says
Conference/Events	Vincera Pharma to host business news update conference call » 07:58 03/05/21 03/05 07:58 03/05/21 07:58 VINC Vincera Pharma $19.16 / -1.26 (-6.17%) Management, along with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events VINC Vincera Pharma $19.16 / -1.26 (-6.17%) 03/02/21 Vincera Pharma appoints Hermes Garban as CMO, Hans-Georg Lerchen as CSO 02/24/21 Vincera Pharma to host KOL webinar on VIP152 01/07/21 Vincera Pharma changes name to Vincerx 12/23/20 Vincera Pharma comples business combination with LifeSci Acquisition VINC Vincera Pharma $19.16 / -1.26 (-6.17%) 01/06/21 Chardan Vincera Pharma initiated with a Buy at Chardan VINC Vincera Pharma $19.16 / -1.26 (-6.17%) 09/29/20 Fly Intel: Wall Street's top stories at midday 12:00 Today Vincera Pharma - VINC

Events

Earnings calls, analyst events, roadshows and more

Today at 08:30

Employment Situation--Private Payrolls M/M: February 2021 Government Event
Today at 08:30

International Trade in Goods Balance: January 2021 Government Event
Today at 08:30

Manufacturing Payrolls M/M: February 2021 Government Event
Today at 08:30

Employment Situation--Participation Rate: February 2021 Government Event
Today at 08:30

Employment Situation--Average Hourly Earnings M/M: February 2021 Government Event
Today at 08:30

Employment Situation: Non-Farm Payrolls M/M: February 2021 Government Event
Today at 08:30

Employment Situation--Average Hourly Earnings Y/Y: February 2021 Government Event
Today at 08:30

Employment Situation--Unemployment Rate: February 2021 Government Event
Today at 08:30

Employment Situation: Average Workweek: February 2021 Government Event
SUP
Today at 08:30

Superior Industries - SUP Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan Priced at: $46.50 3.9M Shares INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC Priced at: $28.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLRX X SLRX Salarius Pharmaceuticals Secondary Managers: Ladenburg Priced at: $1.3685 14.615M Shares VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James Priced at: $34.00 2.206M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR Priced at: $11.50 4.35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan Priced at: $73.25 4.65M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham Priced at: $31.00 4.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SUI X SUI Sun Communities Secondary Managers: Citi, BofA, BMO Capital, JPMorgan & RBC Capital Priced at: $140.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRC X AMRC Ameresco Spot Secondary Managers: BofA & Oppenheimer, Baird, Canaccord, Guggenheim, William Blair Priced at: $44.00 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Boise Cascade reports Q4 EPS with items 66c, consensus $1.08

TODAY'S FREE FLY STORIES

Get Full Fly Access